UNITED STATES - The U.S. Food and Drug Administration (FDA) announced the creation of the Office of Dietary Supplement Programs (ODSP) as an official division under the Office of Nutrition Labeling and Dietary Supplements. The new division is assigned to the following tasks:
- Take action to remove from the market supplement products that are dangerous to consumers
- Work with FDA’s Center for Drug Evaluation and Research to help remove from the market products falsely labeled as dietary supplements that contain potentially harmful pharmaceutical agents
- Enforce the dietary supplement good manufacturing practices (GMP) regulation, giving priority to cases in which GMP violations:
o Potentially compromise product safety
o Fail to ensure product identity, potentially jeopardizing consumer safety
o Result in consumer deception, when, for example, manufacturers do not verify the identity of their raw materials
The creation of the new division is made following an increase in dietary supplements issues over the past several years.